IN2013MU03424A - - Google Patents

Info

Publication number
IN2013MU03424A
IN2013MU03424A IN3424MU2013A IN2013MU03424A IN 2013MU03424 A IN2013MU03424 A IN 2013MU03424A IN 3424MU2013 A IN3424MU2013 A IN 3424MU2013A IN 2013MU03424 A IN2013MU03424 A IN 2013MU03424A
Authority
IN
India
Prior art keywords
core
relates
composition
oxcarbazepine
salts
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Manohar Lalge
Vinayak Kadam
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/065638 priority Critical patent/WO2015063670A1/en
Priority to IN3424MU2013 priority patent/IN2013MU03424A/en
Publication of IN2013MU03424A publication Critical patent/IN2013MU03424A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3424MU2013 2013-10-30 2014-10-27 IN2013MU03424A (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/065638 WO2015063670A1 (en) 2013-10-30 2014-10-27 Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof
IN3424MU2013 IN2013MU03424A (enExample) 2013-10-30 2014-10-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3424MU2013 IN2013MU03424A (enExample) 2013-10-30 2014-10-27

Publications (1)

Publication Number Publication Date
IN2013MU03424A true IN2013MU03424A (enExample) 2015-07-31

Family

ID=54397476

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3424MU2013 IN2013MU03424A (enExample) 2013-10-30 2014-10-27

Country Status (1)

Country Link
IN (1) IN2013MU03424A (enExample)

Similar Documents

Publication Publication Date Title
UY32427A (es) Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
BR112012027509A8 (pt) Composto pirazolil-quinoxalina inibidor de quinase, combinação, produto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e método
UA117098C2 (uk) Сполука, що містить модифікований олігонуклеотид
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
JO3419B1 (ar) مركبات بيريدوبيرازين مضادة للسرطان من خلال تثبيط إنزيمات كيناز fgfr
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
HK1217215A1 (zh) 用於改变细胞表型的信号传感器多核苷酸
PH12012501390A1 (en) Fatty acid fumarate derivatives and their uses
CL2011002267A1 (es) Compuesto derivado de pirazolopiridina sustituida, inhibidor de la quinasa lrrk2; procedimiento de preparacion de dicho compuesto; composicion farmaceutica; combinacion farmaceutica; uso del compuesto para prevenir o tratar un trastorno seleccionado de cancer y enfermedades neurodegenerativas.
GEP20156231B (en) Agomelatine hydrochloride hydrate and preparation there of
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
MX342976B (es) Uso de melatonina para el tratamiento y/o prevencion de la mucositis.
HK1257171A1 (zh) 間變性淋巴瘤激酶（alk）和絲氨酸富集蛋白激酶 （sppk）的抑制劑及其使用方法
WO2015075062A3 (en) Method of treating hair
GEP20156232B (en) Agomelatine hydrochloride hydrate and preparation thereof
EP3564224A3 (en) Crystalline form of vortioxetine hydrobromide as antidepressant drug
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
EA033769B9 (ru) Отселектированный амид -гидроксимасляной кислоты и его применения при лечении злоупотребления алкоголем
BR112016007031A8 (pt) composição farmacêutica oral sólida, processo para preparar a composição farmacêutica oral sólida, e uso de uma composição farcêutica oral sólida
MX2015007945A (es) Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.
IN2013MU03424A (enExample)
UA110933C2 (uk) Композиція для лікування есенціальної тромбоцитемії